Organogenesis Holdings Inc.

ORGO

Healthcare|Drug Manufacturers - Specialty & Generic|US

$0.81

-0.03 (-3.18%)

DCF Value

$3.83

Tangible Book / Share

$1.79

Cash / Share

$0.17

Clinical Trials (38)

Trial	Conditions	Phase	Status	Enrollment	Design	Drug
NCT06618612 A Study to Evaluate the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers	Diabetic Foot Ulcer	N/A	Recruiting	170	RCT, Open-label	—
NCT07510412 Clinical Trial Evaluating NuShield® Plus Standard of Care (SOC) Versus Standard of Care (SOC) Alone in the Management of Non-Healing Venous Leg Ulcers (VLUs)	Venous Leg Ulcers	N/A	Recruiting	200	RCT, Single-blind	—
NCT01619670 A Observational Study to Evaluate Apligraf(R) in Nonhealing Wounds of Subjects With Epidermolysis Bullosa	Epidermolysis Bullosa, Wound Healing	P4	Terminated	3	Open-label	—
NCT02011724 A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®	Venous Leg Ulcers	P4	Unknown	100	Open-label	—
NCT00648674 A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers	Varicose Ulcer	P4	Withdrawn	—	Open-label	—
NCT01327937 A Post Marketing Study of Apligraf in Non-healing Wounds of Subjects With Venous Leg Ulcers	Venous Ulcer	P4	Completed	30	RCT, Single-blind	—
NCT01181453 Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers	Diabetic Foot Ulcer	P3	Completed	314	RCT, Single-blind	—
NCT00512538 Apligraf Versus Standard Therapy in the Treatment of Diabetic Foot Ulcers	Diabetic Foot	P3	Terminated	82	RCT, Open-label	—
NCT06000410 A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee	Knee Osteoarthritis	P3	Completed	594	RCT, Double-blind	Amniotic Suspension Allograft, Placebo
NCT01181440 Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers	Diabetic Foot Ulcer	P3	Completed	281	RCT, Single-blind	—
NCT00909870 Pivotal Trial of Dermagraft(R) to Treat Venous Leg Ulcers	Venous Leg Ulcer	P3	Completed	537	RCT, Open-label	—
NCT00587223 Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)	Epidermolysis Bullosa, Junctional, Epidermolysis Bullosa Dystrophica	P3	Terminated	1	RCT, Open-label	—
NCT04636229 Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee	Knee Osteoarthritis	P3	Completed	516	RCT, Double-blind	Amniotic Suspension Allograft, Placebo
NCT00587834 Safety and Efficacy of Gintuit(TM)for Oral Soft Tissue Regeneration	Gingival Recession	P3	Completed	96	RCT, Open-label	—
NCT00679081 A Pilot Study of CelTx(TM) (Apligraf®) in the Treatment of Gingival Recession Requiring Root Coverage	Gingival Recession	P1P2	Terminated	15	RCT, Open-label	—
NCT01929954 Safety Study of Gintuit™ in Subjects Requiring Socket Grafting	Edentulous Alveolar Ridge	P1P2	Terminated	5	RCT, Open-label	Gintuit
NCT00587587 A Pilot Study of Apligraf for the Treatment and Prevention of Recurrence of Excised Keloids	Keloid	P1P2	Completed	30	RCT, Open-label	—
NCT02318511 An Investigation of ReNu™ Knee Injection in Patients With Osteoarthritis	Osteoarthritis	N/A	Completed	200	RCT, Single-blind	—
NCT01547962 A Pilot Clinical Trial of Gintuit (TM)in Establishing a Functional Zone of Attached Gingiva	Gingival Recession	N/A	Completed	25	RCT, Open-label	—
NCT02880592 Effect of Fresh Amniotic Membrane in the Treatment of Diabetic Foot Ulcers	Diabetic Foot Ulcers	N/A	Completed	89	RCT, Open-label	—
NCT03070925 Prospective PuraPly™ AM Case Series Study	Pressure Ulcers, Venous Ulcers		Completed	43	—	—
NCT02461641 NuShield/Affinity for the Treatment of Neuropathic Diabetic Foot Ulcers	Foot Ulcer, Diabetic	N/A	Completed	96	RCT, Open-label	—
NCT01623882 Clinical Evaluation of the Combined Use of Apligraf® and the SNaP® Pressure Wound Therapy System	Diabetic Foot Ulcer		Withdrawn	—	—	—
NCT02837484 NuTech Affinity™ for the Treatment of Chondral Defects	Chondral Lesions, Cartilage	N/A	Unknown	10	Open-label	—
NCT03286452 The RESPOND Registry	Partial Thickness Wound, Pressure Ulcer		Completed	310	—	—
NCT02808234 Study of Nucel for One and Two Level Lumbar Interbody Fusion	Degenerative Disc Disease, Spondylolisthesis	N/A	Unknown	200	Open-label	—
NCT04901013 Clinical Study Of Affinity Versus SOC In The Management Of VLUs	Venous Leg Ulcer	N/A	Unknown	200	RCT, Open-label	—
NCT03502824 PuraPly® AM Plus the Standard of Care to Standard of Care Alone for the Management of Stage II-IV Pressure Ulcers.	Chronic Pressure Ulcers	N/A	Terminated	40	RCT, Open-label	—
NCT01292122 Safety Study of VCT-01™ in Split-Thickness Skin Graft Donor Site Wounds	Wounds	N/A	Terminated	3	RCT, Open-label	—
NCT03036878 ReNu™ Marrow Stimulation Augmentation	Osteochondral Defect	N/A	Terminated	1	Open-label	—
NCT03828916 NuShield in Surgical Peroneal Tendon Repair	Tendon Injuries, Tendinopathy	N/A	Unknown	30	Open-label	—
NCT02982226 ReNu™ vs. Corticosteroids for the Treatment of Plantar Fasciitis	Fasciitis, Plantar	N/A	Unknown	150	RCT, Single-blind	—
NCT03855514 Randomized Clinical Study Assessing NuShield Versus Standard of Care in Diabetic Foot Ulcers	Diabetic Foot Ulcer	N/A	Unknown	200	RCT, Open-label	—
NCT03070938 PuraPly™ Antimicrobial Wound Matrix and Wound Management	Pressure Ulcer, Venous Ulcer		Completed	100	—	—
NCT03205436 Affinity Prospective Diabetic Foot Trial Crossover Group	Diabetic Foot Ulcer	N/A	Completed	20	Open-label	—
NCT01134081 Expression of Angiogenic Biomarkers During Healing of Intra-Oral Soft Tissue Engineered Grafts	Gingival Recession	N/A	Completed	44	RCT, Open-label	CelTx™
NCT03063099 ReNu™ Injection to Treat Hip Osteoarthritis Study	Osteoarthritis, Hip	N/A	Completed	10	Open-label	—
NCT02023372 Efficacy Study of NuCel® in Patients Undergoing Fusion of the Lumbar Spine	Intervertebral Disc Disease, Intervertebral Disc Degeneration	N/A	Completed	57	Open-label	—